Recombinant PD-L1 antibody
Quick Overview for Recombinant PD-L1 antibody (ABIN7862915)
Target
See all PD-L1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Expression System
- CHO Cells
-
Purpose
- Recombinant PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) Antibody
-
Specificity
- PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.
-
Purification
- 200ug/ml of Ab produced in CHO cell mammalian-based expression system.
-
Immunogen
- KLH-conjugated linear peptide corresponding to human PD-L1
-
Isotype
- IgG2a, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Expiry Date
- 24 months
-
-
- PD-L1 (CD274 (PD-L1))
-
Alternative Name
- PD-L1
-
Background
-
B7 homolog 1, B7-H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1
Human placenta, spleen or tonsil tissue.
-
Molecular Weight
- 37-50kDa
-
Gene ID
- 29126, 521989
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Target
-